Cargando…

Asthma: From Phenotypes to Personalized Medicine

Detalles Bibliográficos
Autor principal:	Bakakos, Petros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697981/ https://www.ncbi.nlm.nih.gov/pubmed/36579604 http://dx.doi.org/10.3390/jpm12111853

Ejemplares similares

Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023)

Identification of asthma phenotypes using blood cell count
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Severe Eosinophilic Asthma
por: Bakakos, Agamemnon, et al.
Publicado: (2019)

Unraveling the Relationship of Asthma and COVID-19
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Biological Therapy of Severe Asthma and Nasal Polyps
por: Bakakos, Agamemnon, et al.
Publicado: (2022)

Personalized medicine for asthma: Are we there yet?
por: Poon, Audrey H., et al.
Publicado: (2012)

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Asthma Phenotypes in the Era of Personalized Medicine
por: Gonzalez-Uribe, Victor, et al.
Publicado: (2023)

Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach
por: Bakakos, Agamemnon, et al.
Publicado: (2022)

Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
por: Bakakos, Agamemnon, et al.
Publicado: (2023)

Personalized Medicine in Asthma: Current Approach and Future Perspectives
por: Nolasco, Santi, et al.
Publicado: (2023)

Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016)

Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?
por: Voulgareli, Ilektra, et al.
Publicado: (2023)

Fever and multilobular mass of the right lung in a young adult with asthma
por: Sotiriou, Adamantia, et al.
Publicado: (2015)

Extrafine Beclometasone Dipropionate/Formoterol NEXThaler on Device Usability, Adherence, Asthma Control and Quality of Life. A Panhellenic Prospective, Non-Interventional Observational Study in Patients with Asthma—The NEXT-Step Study
por: Bakakos, Petros, et al.
Publicado: (2022)

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm
por: Tomos, Ioannis, et al.
Publicado: (2020)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

Personalized Approach to Severe Asthma
por: Heffler, Enrico, et al.
Publicado: (2018)

Asthma phenotypes in primary care
por: Honkoop, Persijn J., et al.
Publicado: (2020)

From Evidence-based Medicine to Personalized Medicine
por: Lee, Suk-Hwan
Publicado: (2012)

Computerized Tomographic Assessment for Phenotyping Asthma
por: Seo, Joon Beom
Publicado: (2023)

Severe asthma phenotyping: does the definition of different phenotypes matter?
por: Pizzichini, Marcia Margaret Menezes, et al.
Publicado: (2022)

Personal phenotypes to go with personal genomes
por: Snyder, Michael, et al.
Publicado: (2009)

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

From basic research to personalized medicine
por: Thibaut, Florence
Publicado: (2016)

Blood molecular biomarkers of the inflammatory phenotypes of asthma
por: Kim, Sae-Hoon
Publicado: (2020)

Implication of IL-18 in chronic inflammation of severe refractory asthma
por: Rovina, Nikoletta, et al.
Publicado: (2015)

Traditional Herbal Medicine and Allergic Asthma
por: Lin, Bi-Fong, et al.
Publicado: (2015)

Personalized Medicine in Oncology; a Special Issue of the Journal of Personalized Medicine
por: VanderWalde, Ari
Publicado: (2021)

The overlap phenotype: the (missing) link between asthma and COPD
por: Piras, Barbara, et al.
Publicado: (2012)

Modern Inflammatory Phenotyping of Asthma. Breathomics Is Here to Stay
por: Sterk, Peter J.
Publicado: (2019)

Is a Longitudinal Trajectory Helpful in Identifying Phenotypes in Asthma?
por: Kim, Tae-Bum
Publicado: (2018)

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
por: Bakakos, Petros, et al.
Publicado: (2022)

Personalized Medicine in Epidemics
por: Middelburg, Rutger A.
Publicado: (2022)

Personalized Medicine: Pharmacokinetics
por: Daali, Youssef
Publicado: (2022)

Personalized medicine for schizophrenia
por: Buckley, Peter F., et al.
Publicado: (2017)

Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020)

Allergic Asthma in the Era of Personalized Medicine
por: Papapostolou, Niki, et al.
Publicado: (2022)

Depression Levels Influence the Rate of Asthma Exacerbations in Females
por: Anastasia, Papaporfyriou, et al.
Publicado: (2021)

Personalized Medicine: A Tailor Made Medicine
por: Akhondzadeh, Shahin
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6h5b10pi92elgjr0h5fspqfjef